Latest

Inverted ILM flap technique improves outcomes of macular hole surgery
OCTA: Future Is bright, fast, and wide in ROPAdvances in optical coherence tomography (OCT) and OCT angiography (OCTA) may enable more objective and accurate diagnosis of ROP in the future.
Subretinal therapy offers promise of lighter treatment burden for AMDRGX-314 gene therapy offers patients the potential for a lower treatment burden with one subretinal injection of a gene therapy delivering an anti-vascular endothelial growth factor protein.
Experts weigh in on Retina Subspecialty Day
Drs. Wykoff, Kim and Spaide summarize day-two of Retina Subspecialty Day at AAO 2017
Drs. Wykoff, Kim and Spaide summarize day-two of Retina Subspecialty Day at AAO 2017
Uveitis updates from Retina Subspecialty Day 2017
OCTA providing two-for-one imaging and practical valueOCT angiography (OCTA) is a revolutionary new tool that adds value to clinical practice. It provides unique insights about retinal and choroidal vasculature compared with conventional OCT along with the advantages of conventional dye-based techniques, said Philip J. Rosenfeld, MD, PhD, at the 2017 Retina Subspecialty Day meeting.
Tumor-targeted therapy changing game for choroidal melanomaEarly results of a phase Ib/II study investigating light-activated AU-011 (Aura Biosciences) for treatment of small-medium choroidal melanoma show good safety and evidence of efficacy for this novel tumor-targeted therapy.
NLP status after open-globe injury not always permanentManagement of patients with loss of light perception after open-globe injury has historically been to observe or enucleate the eye with the goal of reducing the risk of sympathetic ophthalmia. Existing data, however, support rethinking that paradigm and instead considering surgery for carefully selected patients who have a chance for recovering vision.
Highlights from Day 2 of Retina Subspecialty Day 2017
var script= ' ';